1.5 Poor Metabolizers of CYP2C9 Substrates
Celecoxib should be initiated at half the lowest recommended dose in patients who are known or suspected to be poor CYP2C9 metabolizers1-4.
Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.